Global /China /Basic Materials /Specialty Chemicals /688089

Cabio Biotech (Wuhan) Co., Ltd.

688089

• SSE: 688089 • Delayed

16.03CNY -0.2%

2.37 USD

As of 18 June 2026, Cabio Biotech (Wuhan) Co., Ltd. has a market cap of $396.39M USD, ranking #16768 globally and #5242 in China. It ranks #1784 in the Basic Materials sector, and #595 in the Specialty Chemicals industry.

Global Rank

16768

Country Rank

5242

Sector Rank

1784

Industry Rank

595

Key Stats

Market Cap

$396.39MUSD

2.68B CNY

Enterprise Value

$370.94MUSD

2.51B CNY

Revenue (TTM)

$61.88MUSD

418.18M CNY

EBITDA (TTM)

$18.66MUSD

126.13M CNY

Net Income (TTM)

$8.16MUSD

55.16M CNY

EBITDA Margin

30%

Profit Margin

13%

PE Ratio

48.7

PS Ratio

6.4

PB Ratio

1.7

EV/EBITDA

19.8

Company Profile

Country (HQ)

China

Sector

Basic Materials

Industry

Specialty Chemicals

CEO

Dewei Yi open_in_new

Employees

574

Founded

1999

Website

cabio.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.2%	0.1%	-12%	-15%	-33%	-31%	-36%	-30%	-48%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688089 嘉必优生物技术（武汉）股份有限公司 Class A ISIN: CNE100005X31 Shares Out.: Shares Outstanding: 166.36M¹ Shares Float: 166.352M² TV: TradingView: SSE: 688089 SA: Stock Analysis: SHA: 688089 YF: Yahoo Finance: 688089.SS GF: Google Finance: SHA: 688089 BA: Barron's: 688089 MS: Morningstar: XSHG: 688089	16.03 CNY	TV: TradingView: SSE: 688089 SA: Stock Analysis: SHA: 688089 YF: Yahoo Finance: 688089.SS GF: Google Finance: SHA: 688089 BA: Barron's: 688089 MS: Morningstar: XSHG: 688089

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Cabio Biotech (Wuhan) Co., Ltd.

Cabio Biotech (Wuhan) Co., Ltd. develops, produces, and markets arachidonic and docosahexaenoic acids, and beta-carotene for domestic and foreign infant formula, and healthy food manufacturers. It offers human and animal nutrition, personal care, and synthetic biology products. The company was founded in 1999 and is based in Wuhan, the People’s Republic of China.

Similar Companies

Industry: Specialty Chemicals (China)

Name	Market Cap (USD) diff.	PE	Country
Wanhua Chemical Group Co., Ltd. SSE: 600309	$41.48B 280.3B CNY 10K%	21.3	China
Ningxia Baofeng Energy Group Co., Ltd. SSE: 600989	$33.5B 226.4B CNY 8K%	18.0	China
China Northern Rare Earth (Group) High-Tech Co.,Ltd SSE: 600111	$27.25B 184.19B CNY 7K%	67.3	China
Ganfeng Lithium Group Co., Ltd. SHE: 002460	$25.8B 174.39B CNY 6K%	47.3	China
Hengli Petrochemical Co.,Ltd. SSE: 600346	$23.14B 156.41B CNY 6K%	17.4	China
China Jushi Co., Ltd. SSE: 600176	$20.96B 141.68B CNY 5K%	37.3	China

Industry: Specialty Chemicals (Global)

Name	Market Cap (USD) diff.	PE	Country
Linde plc NASDAQ: LIN	$233.88B 59K%	34.5	United Kingdom
Air Liquide S.A. EPA: AI	$121.68B 104.79B EUR 31K%	29.9	France
Shin-Etsu Chemical Co., Ltd. TSE: 4063	$81.92B 13.15T JPY 21K%	28.0	Japan
The Sherwin-Williams Co. NYSE: SHW	$77.94B 20K%	30.5	United States
Ecolab Inc. NYSE: ECL	$72.47B 18K%	34.7	United States
Air Products and Chemicals, Inc. NYSE: APD	$67.35B 17K%	-	United States

chevron_leftBack